var ps = ["index.html","Introduction.html","SectAClasDiagInitManaPrevAndScre.html","A10TypesOfDiabetes.html","A20ConfTheDiagAndInitMana.html","A21ConfirmingTheDiagnosis.html","A211InteOfPlasGlucLeveMmolL.html","A212InteOf75gOralGlucToleTestWHO.html","A22DeteTheRiskOfKetoAndLikeNeedF.html","A221IndiForImmeInsuTher.html","A222PatiNotRequImmeInsu.html","A23ChecListForReceDiagDiab.html","A231Checklist.html","A24ImpaGlucToleAmpImpaFastGluc.html","A25GlycContManaOfTheNewlDiagPati.html","A26PerfA75gOralGlucToleTest.html","A30PreventionOfDiabetes.html","Figure1AHealthyWeightSummary.html","A311AchiAmpMainAHealWeigAmpLife.html","A312KeyFactsWhatIsAHealthyWeight.html","A313KeyFactsEatingAHealthyDiet.html","A314KeyFactsPhysicalActivity.html","A315KeyFactHealLifeAmpAlco.html","A3151WhatIsAUnitOfAlcohol.html","A316KeyFactMediAmpSurgAsPartOfTh.html","A317SourOfAdviAbouHowToAchiAndMa.html","A40ScreeningForDiabetes.html","A41UKNatiScreCommUKNSC.html","A411SummOfEvidRegaScreForDiab.html","SectionBSupportingSelfManagement.html","B10StructuredReviewSchedules.html","B11RegularReviewSchedules.html","B12EveryStructuredDiabeticReview.html","B13ContentOfAnnualChecks.html","B20Education.html","B21NewlyDiagnosedDiabetes.html","B22OngoingDiabetesManagement.html","B23DiabetesCoursesAmpResources.html","B30Lifestyle.html","B31Driving.html","B32Occupations.html","B33PhysicalActivity.html","B34PsychologicalWellbeing.html","B341Introduction.html","B342Depression.html","B343Anxiety.html","B344ScreForAnxiAndDepr.html","B345OtherPsychologicalIssues.html","B346BehaviourChange.html","B35Smoking.html","B351SmokingCessation.html","B36Travel.html","TravLettForPatiUsinInsu.html","B40InformationTechnology.html","B41Appe1SCIDCBackPopuDiabRelaGMS.html","B50ContPregAndTheManaOfGestDiabM.html","B501PatientInformation.html","B502Introduction.html","B51Contraception.html","B52PlanningPregnancy.html","B53ConfirmedPregnancy.html","B54ManaOfGestDiab.html","B541FollUpOfPatiWithPrevGestDiab.html","B60ChildrenSServices.html","SectionCGlycaemicControl.html","C10TargetsForGlycaemicControl.html","C11GlycosylatedHaemoglobin.html","C12ConvTablForHbA1ToMmolMol.html","C20Monitoring.html","C21PatiWithType2DiabContByDietOr.html","C22PatiWithInsuTreaDiab.html","C23AdjustmentOfInsulinDose.html","C24KetoTestInInsuTreaPati.html","C241ManagementOfResults.html","C25BLOOGLUCMETELANCLANC.html","C30HypoglycaemicDrugTherapy.html","C31OralHypoglycaemicDrugs.html","C311CompCostOfTreaForType2Diab.html","C32InsulinRegimens.html","C33TypesOfInsulin.html","C34SummOfInsuClas.html","C341InsulinCosts.html","C40Hypoglyaemia.html","C41CausesOfHypoglycaemia.html","C42SymptomsOfHypoglycaemia.html","C43HypoglycaemiaUnawareness.html","C44TreatmentOfHypoglycaemia.html","C45HypoAndSulp.html","C46NocturnalHypoglycaemia.html","C47ReboundHyperglycaemia.html","C48AvoidanceOfHypoglycaemia.html","C49DrivingAndHypoglycaemia.html","C410ExerciseRelatedHypoglycaemia.html","C50ManaOfDiabEmerInTheComm.html","C60ManaOfDiabInHosp.html","C61Introduction.html","C62DiabeticEmergencies.html","C621DiabeticKetoAcidosisDKA.html","C622HypeHypeNonKetoSyndHHNS.html","C623HypoglycaemiaInHospital.html","C624TreatmentOfHypoglycaemia.html","C625WhenHypoHasBeenSuccTrea.html","C626PrevOfHypoDuriHospAdmi.html","C63ManaOfDiabDuriInteIlln.html","C631Type1Diabetes.html","C632Type2Diabetes.html","C633VariRateIntrInsuInfu.html","C634PROTFORVARIRATEINTRINSUINFU.html","C64GuidForDiabManaDuriProcRequFa.html","SectionDComplications.html","D10BloodPressure.html","D11SIGN116AntiTher.html","D20CardDiseAndDiab.html","D21Screening.html","D22SpecCardProtTher.html","D23Lipids.html","D30EyeCareScreeningAndTreatment.html","D31EyeScreening.html","D32Mydriasis.html","D33MedicalTreatment.html","D34LaserTreatment.html","D35DiabEyeScreGuidClasAndActi.html","D351VisualAcuity.html","D36Fundoscopy.html","D37ScotDiabRetiGradSche2007V11.html","D38ObtaIndiPatiResu.html","D40FootCareScreeningAndTreatment.html","D41FootScreening.html","D411SCIDCFootScreeningTool.html","D412AnnualDiabeticFootScreening.html","D413DiabFootRiskStraAndTriaTrafL.html","D42ManaGuidForCharNeurInPeopWith.html","D43DiabFootUlceAndWounMana.html","D431CarePathForActiDiabFootUlce.html","D432RefePathForPresReli.html","D433PainfulDiabeticNeuropathy.html","D44GoodPracGuidForTheUseOfAntiIn.html","D441Introduction.html","D442GeneralApproachToFootUlcers.html","Table1IDSAGuidelines.html","D443GenePrinOfAntiUse.html","Figu1UnivOfTexaClasSystForDiabFo.html","D45SpecAntiGuidSeeTabl2ForSumm.html","D451MildInfeIDSAOrPEDI2AndThePat.html","D452aModeIDSAOrPEDI3AndThePatiIs.html","D452bModeIDSAOrPEDI3AndThePatiIs.html","D453aSeveInfeIDSAOrPEDI4AntiNaVe.html","D453bSeveInfeIDSAOrPEDI4AndThePa.html","D454Osteomyelitis.html","Tabl2SummOfGoodPracStatOnAntiCho.html","Tabl3EmpiGuidAsToWhicOrgaAreLike.html","D455BiblForGoodPracGuidForTheUse.html","D46DiabFootCarePatiEduc.html","D60RenalDisease.html","D61ScreForDiabRenaDise.html","D62Definitions.html","D621AsseOfDipsPosiPati.html","D622AsseOfDipsNegaPati.html","D623AlgoForMicrScreInTheComm.html","D63ASimpGuidToEGFRInteAndNephRef.html","D64ManaOfDiabRenaDise.html","D65RefeForSpecRenaAdvi.html"];
var ts = ["Cover","Introduction","Section A: Classification, Diagnosis Initial Management, Prevention and Screening","A1.0 Types of Diabetes","A2.0 Confirming the Diagnosis and Initial Management","A2.1 Confirming the diagnosis","A2.1.1 Interpretation of Plasma Glucose Levels (mmol/l)","A2.1.2 Interpretation of 75g Oral Glucose Tolerance Test (WHO 2000)","A2.2 Determine the risk of ketoacidosis and likely need for immediate insulin therapy","A2.2.1 Indications for immediate insulin therapy","A2.2.2 Patients not requiring immediate insulin","A2.3 Check list for recently diagnosed diabetes","A2.3.1 Checklist","A2.4 Impaired glucose tolerance & impaired fasting glucose","A2.5 Glycaemic control - management of the newly diagnosed patient:","A2.6 Performing a 75g Oral Glucose Tolerance Test","A3.0 Prevention of Diabetes","Figure 1 – A Healthy Weight (Summary)","A3.1.1 Achieving & Maintaining a Healthy Weight & Lifestyle","A3.1.2 Key Facts – What is a healthy weight?","A3.1.3 Key Facts – Eating a Healthy Diet","A3.1.4 Key Facts – Physical Activity","A3.1.5 Key Facts: Healthy Lifestyle & Alcohol","A3.1.5.1 What is a unit of alcohol?","A3.1.6 Key Facts: Medicines & Surgery as part of the management of obesity","A3.1.7 Sources of advice about how to achieve and maintain a healthy weight & lifestyle","A4.0 Screening for diabetes","A4.1 UK National Screening Committee (UK NSC)","A4.1.1 Summary of evidence regarding screening for diabetes","Section B: Supporting Self-Management","B 1.0 Structured Review Schedules","B1.1 Regular Review Schedules","B1.2 Every structured diabetic review","B1.3 Content of Annual Checks","B2.0 Education","B2.1 Newly Diagnosed Diabetes","B2.2 Ongoing Diabetes Management","B2.3 Diabetes Courses & Resources","B3.0 Lifestyle","B3.1 Driving","B3.2 Occupations","B3.3 Physical Activity","B3.4 Psychological Wellbeing","B3.4.1 Introduction","B3.4.2 Depression","B3.4.3 Anxiety","B3.4.4 Screening for Anxiety and Depression","B3.4.5 Other Psychological Issues","B3.4.6 Behaviour Change","B3.5 Smoking","B3.5.1 Smoking cessation","B3.6 Travel","Travel Letter for Patients Using Insulin","B4.0 Information Technology","B4.1 Appendix 1 – SCI-DC Back-Population: Diabetes-Related GMS Contract Indicators","B5.0 Contraception, Pregnancy and the Management of Gestational Diabetes Mellitus","B5.0.1 Patient information","B5.0.2 Introduction","B5.1 Contraception","B5.2 Planning pregnancy","B5.3 Confirmed pregnancy","B5.4 Management of Gestational Diabetes","B5.4.1 Follow up of Patients with Previous Gestational Diabetes","B6.0 Children’s Services","Section C: Glycaemic Control","C1.0 Targets for Glycaemic Control","C1.1 Glycosylated haemoglobin","C1.2 Conversion Table for HbA1c % to mmol/mol","C2.0 Monitoring","C2.1 Patients with Type 2 Diabetes controlled by diet or oral medication","C2.2 Patients with Insulin-treated Diabetes","C2.3 Adjustment of insulin dose","C2.4 Ketone testing in insulin-treated patients","C2.4.1 Management of results:","C2.5 BLOOD GLUCOSE METERS / LANCERS / LANCETS",". C3.0 Hypoglycaemic Drug Therapy","C3.1 Oral hypoglycaemic drugs","C3.1.1 Comparative Costs of Treatments for Type 2 Diabetes","C3.2 Insulin regimens","C3.3 Types of Insulin","C3.4 Summary of insulin classification","C3.4.1 Insulin costs","C4.0 Hypoglyaemia","C4.1 Causes of hypoglycaemia","C4.2 Symptoms of hypoglycaemia","C4.3 Hypoglycaemia unawareness","C4.4 Treatment of hypoglycaemia","C4.5 Hypoglycaemia and sulphonylureas","C4.6 Nocturnal hypoglycaemia","C4.7 Rebound Hyperglycaemia","C4.8 Avoidance of hypoglycaemia","C4.9 Driving and hypoglycaemia","C4.10 Exercise related hypoglycaemia","C5.0 Management of Diabetic Emergencies in the Community","C6.0 Management of Diabetes in Hospital","C6.1 Introduction","C6.2 Diabetic emergencies","C6.2.1.Diabetic Keto Acidosis (DKA)","C6.2.2 Hyperosmolar Hyperglycaemic Non Ketotic syndrome (HHNS)","C6.2.3 Hypoglycaemia in hospital","C6.2.4 Treatment of hypoglycaemia","C6.2.5 When hypoglycaemia has been successfully treated","C6.2.6 Prevention of Hypoglycaemia during Hospital Admission","C6.3 Management of Diabetes during intercurrent illness","C6.3.1 Type 1 diabetes","C6.3.2 Type 2 diabetes","C6.3.3 Variable rate intravenous insulin infusion","C6.3.4 PROTOCOL FOR VARIABLE RATE INTRAVENOUS INSULIN INFUSIONS","C6.4 Guidelines for diabetes management during procedures requiring fasting","Section D: Complications","D1.0 Blood Pressure","D1.1 SIGN 116 Antihypertensive therapy","D2.0 Cardiovascular disease and diabetes","D2.1 Screening","D2.2 Specific cardio-protective therapy","D2.3 Lipids","D3.0 Eye Care, Screening and Treatment","D3.1 Eye screening","D3.2 Mydriasis","D3.3 Medical treatment","D3.4 Laser treatment","D3.5 Diabetic eye screening guidelines - classification and action","D3.5.1 Visual acuity","D3.6 Fundoscopy","D3.7 Scottish Diabetic Retinopathy Grading Scheme 2007 v1.1","D3.8 Obtaining individual patient results","D4.0 Foot Care, Screening and Treatment","D4.1 Foot Screening","D4.1.1 SCI-DC Foot Screening Tool","D4.1.2 Annual Diabetic Foot Screening","D4.1.3 Diabetic Foot Risk Stratification and Triage “Traffic Lights”","D4.2 Management guidelines for Charcot neuroarthropathy in people with diabetes","D4.3 Diabetic Foot Ulceration and Wound Management","D4.3.1 Care Pathway for Active Diabetic Foot Ulceration","D4.3.2 Referral Pathway for Pressure Relief","D4.3.3Painful Diabetic Neuropathy","D4.4 Good practice guidance for the use of antibiotics in patients with diabetic foot ulcers","D 4.4.1 Introduction","D 4.4.2 General Approach to Foot Ulcers","Table 1 – IDSA Guidelines","D 4.4.3. General Principles of Antibiotic Use","Figure 1 – University Of Texas Classification System for Diabetic Foot Wounds","D4.5 Specific Antibiotic Guidance (see Table 2 for summary)","D4.5.1 Mild infection (IDSA) or (PEDIS 2) and the patient is antibiotic naïve.","D4.5.2a Moderate (IDSA) or PEDIS 3 and the patient is antibiotic naïve.","D4.5.2b Moderate (IDSA) (or PEDIS 3) and the patient is NOT antibiotic naïve.","D4.5.3a Severe infection (IDSA) (or PEDIS 4), antibiotic naïve.","D4.5.3b Severe infection (IDSA) (or PEDIS 4) and the patient is not antibiotic naïve and has risk factors for drug resistant infection","D4.5.4. Osteomyelitis","Table 2 – Summary of good practice statement on antibiotic choice for the diabetic foot.","Table 3 – Empirical guide as to which organisms are likely to be the infecting organism and which antibiotics are likely to be effective.","D4.5.5 – Bibliography for good practice guidance for the use of antibiotics in patients with diabetic foot ulcers","D4.6 Diabetic Foot Care Patient Education","D6.0 Renal Disease","D6.1 Screening for diabetic renal disease","D6.2 Definitions","D6.2.1 Assessment of dipstick positive patients","D6.2.2 Assessment of dipstick negative patients","D6.2.3 Algorithm for microalbuminuria screening in the community","D6.3 A simple guide to eGFR interpretation and nephrology referral guidelines.","D6.4 Management of Diabetic Renal Disease","D6.5 Referral for specialist renal advice"];